Nothing Special   »   [go: up one dir, main page]

Ruiu et al., 2021 - Google Patents

Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer

Ruiu et al., 2021

View HTML
Document ID
6084943318323339650
Author
Ruiu R
Barutello G
Arigoni M
Riccardo F
Conti L
Peppino G
Annaratone L
Marchiò C
Mengozzi G
Calogero R
Cavallo F
Quaglino E
Publication year
Publication venue
Cancers

External Links

Snippet

Simple Summary Patients with triple negative breast cancer (TNBC) experience shorter overall survival compared to non-TNBC patients because of the high incidence of recurrences and metastases. This is due to the capacity of aggressive cancer cell …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/12Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Das et al. Nuclear respiratory factor 1 acting as an oncoprotein drives estrogen-induced breast carcinogenesis
Kim et al. STAT3 inhibitor ODZ10117 suppresses glioblastoma malignancy and prolongs survival in a glioblastoma xenograft model
Wang et al. Cd44 promotes lung cancer cell metastasis through erk–zeb1 signaling
Kang et al. Cancer-associated fibroblast subgroups showing differential promoting effect on hnscc progression
Lee et al. Upregulation of CD109 promotes the epithelial-to-mesenchymal transition and stemness properties of lung adenocarcinomas via activation of the hippo-YAP signaling
Peltanova et al. Sensitivity to cisplatin in head and neck cancer cells is significantly affected by patient-derived cancer-associated fibroblasts
Tong et al. LncRNA HCP5-encoded protein regulates ferroptosis to promote the progression of triple-negative breast cancer
Takahashi et al. AKT3 is a novel regulator of cancer-associated fibroblasts in head and neck squamous cell carcinoma
Akinjiyan et al. DDR2 expression in cancer-associated fibroblasts promotes ovarian cancer tumor invasion and metastasis through periostin-ITGB1
Ruiu et al. Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer
Kupczyk et al. PARP1 as a marker of an aggressive clinical phenotype in cutaneous melanoma—a clinical and an in vitro study
Oh et al. Genome-wide transcriptomic analysis of non-tumorigenic tissues reveals aging-related prognostic markers and drug targets in renal cell carcinoma
Huang et al. Pan-cancer analysis reveals SH3TC2 as an oncogene for colorectal cancer and promotes tumorigenesis via the MAPK pathway
Yunusova et al. Comparative analysis of tumor-associated microRNAs and tetraspanines from exosomes of plasma and ascitic fluids of ovarian cancer patients
Tachon et al. MEOX2 transcription factor is involved in survival and adhesion of glioma stem-like cells
Fan et al. Siglec-15 as a new perspective therapy target in human giant cell tumor of bone
Koni et al. Interleukin-3-receptor-α in triple-negative breast cancer (TNBC): an additional novel biomarker of TNBC aggressiveness and a therapeutic target
Lebedev et al. Targeting ARID1A-deficient cancers: an immune-metabolic perspective
Sadeghi et al. Differential B-cell receptor signaling requirement for adhesion of mantle cell lymphoma cells to stromal cells
Izraely et al. The vicious cycle of melanoma-microglia crosstalk: inter-melanoma variations in the brain-metastasis-promoting Il-6/Jak/Stat3 signaling pathway
Yoon et al. Sp1-induced FNBP1 drives rigorous 3D cell motility in EMT-type gastric cancer cells
Iommelli et al. A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors
Vargas-Accarino et al. Spontaneous cell detachment and reattachment in cancer cell lines: an in vitro model of metastasis and malignancy
Treese et al. S100A4 is a strong negative prognostic marker and potential therapeutic target in adenocarcinoma of the stomach and esophagus
Moiseeva et al. Analysis of multiple drug resistance mechanism in different types of soft tissue sarcomas: assessment of the expression of ABC-transporters, MVP, YB-1, and analysis of their correlation with chemosensitivity of cancer cells